Provided by Tiger Fintech (Singapore) Pte. Ltd.

Iterum Therapeutics Plc

1.41
-0.0200-1.40%
Post-market: 1.410.00000.00%19:51 EDT
Volume:462.44K
Turnover:662.51K
Market Cap:48.76M
PE:-1.12
High:1.48
Open:1.47
Low:1.39
Close:1.43
Loading ...

Iterum Therapeutics Shares Soar on FDA's Orlynvah Approval

Dow Jones
·
26 Oct 2024

Iterum Therapeutics Shares Rise as FDA Approves Orlynvah as Treatment for Uncomplicated Urinary Tract Infections

MT Newswires Live
·
25 Oct 2024

Iterum: in Case Strategic Process Does Not Result in a Deal, May Seek Commercial Partner and/or Look to Commercialize Oral Sulopenem in US Directly

THOMSON REUTERS
·
25 Oct 2024

Iterum Therapeutics Plc - to Renew Efforts for Strategic Transaction Involving Orlynvah

THOMSON REUTERS
·
25 Oct 2024

Iterum Therapeutics announces FDA approval of Orlynvah

TIPRANKS
·
25 Oct 2024

Iterum Therapeutics Receives U.S. FDA Approval of Orlynvah™ (Oral Sulopenem) for the Treatment of Uncomplicated Urinary Tract Infections

THOMSON REUTERS
·
25 Oct 2024

Iterum Therapeutics jumps 20% to $1.41 after FDA posts approval

TIPRANKS
·
25 Oct 2024

BRIEF-FDA Approves Iterum Therapeutics' Orlynvah For Treatment Of Uncomplicated Urinary Tract Infections - Website

Reuters
·
25 Oct 2024

Iterum Therapeutics Shares Halted

THOMSON REUTERS
·
25 Oct 2024

FDA approves Iterum's treatment for urinary infection

Reuters
·
25 Oct 2024

Iterum Therapeutics PLC trading halted, news pending

TIPRANKS
·
25 Oct 2024

FDA Approves Iterum Therapeutics' Orlynvah for Treatment of Uncomplicated Urinary Tract Infections - Website

THOMSON REUTERS
·
25 Oct 2024

What to Watch in the Day Ahead - Friday, October 25

Reuters
·
25 Oct 2024

BRIEF-Iterum Therapeutics Got Delisting Determination Letter Advising That Nasdaq Determined Co Did Not Meet Terms Of Extension For Compliance

Reuters
·
05 Oct 2024

Iterum Therapeutics: Got Delisting Determination Letter Advising That Nasdaq Determined Co Did Not Meet Terms of Extension for Compliance

THOMSON REUTERS
·
05 Oct 2024

Iterum Therapeutics Plc: Egm Adjourned Until Oct 8, 2024- Filing

THOMSON REUTERS
·
01 Oct 2024